COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 2875: Articles 28741-28750  | Next

Regressing SARS-CoV-2 sewage measurements onto COVID-19 burden in the population: a proof-of-concept for quantitative environmental surveillance
Bar Or, I., Yaniv, K., Shagan, M., Ozer, E., Erster, O., Mendelson, E., Mannasse, B., Shirazi, R., Kramarsky-Winter, E., Nir, O., Abu-Ali, H., Ronen, Z., Rinott, E., Lewis, Y. E., Friedler, E. F., Paitan, Y., Bitkover, E., Berchenko, Y., Kushmaro, A.
10.1101/2020.04.26.20073569 — Posted: 2020-05-01 Discussion: Onsite
Methods of An Open-Label Proof-Of-Concept Trial of Intravenous Valproic Acid for Severe COVID-19
Chiquete, E., Toapanta-Yanchapaxi, L., Cantu-Brito, C.
10.1101/2020.04.26.20079988 — Posted: 2020-05-01
Fast and easy disinfection of coronavirus-contaminated face masks using ozone gas produced by a dielectric barrier discharge plasma generator
Lee, J., Bong, C., Bae, P. K., Abafog, A. T., Baek, S. H., Shin, Y.-B., Park, M. S., Park, S.
10.1101/2020.04.26.20080317 — Posted: 2020-05-01
Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; MaastrICCht
Tas, J., van Gassel, R. J., heines, S. J., Mulder, M. M., heijnen, N. F., Acampo - de Jong, M. J., Bels, J. L., Bennis, F. C., Koelmann, M., Groven, R. V., Donkers, M. A., van Rosmalen, F., Hermans, B. J., Meex, S. J., Mingels, A. M., Bekers, O., Savelkoul, P. H., Oude Lashof, A. M., Wildberger, J. E., Tijssen, F. H., Buhre, W. F., Sels, J. E., Ghossein-Doha, C., Driessen, R. G., Kubben, P. L., Janssen, M. L., Nicolaes, G. A., Strauch, U., Geyik, Z., Delnoij, T. S., Walraven, K. H., Stehouwer, C. D., Verbunt, J. A., van Mook, W. N., van Santen, S., Schnabel, R. M., Aries, M. J., van de Poll, M. C., Bergmans, D. C., van der Horst, I. C., van Kuijk, S. M., van Bussel, B. C., Maastricht Intensive Care COVID Study Group
10.1101/2020.04.27.20080309 — Posted: 2020-05-01
Using the COVID-19 to influenza ratio to estimate the numbers of symptomatic COVID-19 cases in Wuhan prior to the lockdown
Du, Z., Cowling, B. J., Meyers, L. A.
10.1101/2020.04.26.20075937 — Posted: 2020-05-01
Impact of virus testing on COVID-19 case fatality rate: estimate using a fixed-effects model
Terriau, A., Albertini, J., Poirier, A., LE BASTARD, Q.
10.1101/2020.04.26.20080531 — Posted: 2020-05-01
MODELLING OF COVID-19 OUTBREAK INDICATORS IN CHINA BETWEEN JANUARY AND APRIL
Celik, S., Ankarali, H., Pasin, O.
10.1101/2020.04.26.20080465 — Posted: 2020-05-01
Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents
L'Huillier, A. G., Torriani, G., Pigny, F., Kaiser, L., Eckerle, I.
10.1101/2020.04.27.20076778 — Posted: 2020-05-01
High frequency of SARS-CoV-2 RNAemia and association with severe disease
Hogan, C. A., Stevens, B., Sahoo, M. K., Huang, C., Garamani, N., Gombar, S., Yamamoto, F., Murugesan, K., Kurzer, J., Zehnder, J., Pinsky, B. A.
10.1101/2020.04.26.20080101 — Posted: 2020-05-01
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
Doi, A., Iwata, K., Kuroda, H., Hasuike, T., Nasu, S., Kanda, A., Nagao, T., Nishioka, H., Tomii, K., Morimoto, T., Kihara, Y.
10.1101/2020.04.26.20079822 — Posted: 2020-05-01 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).